CORBUS PHARMACEUTICALS HLDGS
CRBP·21833P301·US·Common Stock·Healthcare - Biotechnology-13D/G
CRBP (CORBUS PHARMACEUTICALS HLDGS) is held by 59 institutional investors as of Q1 2026. Largest holders: Aberdeen Group plc ($12.4M), VANGUARD CAPITAL MANAGEMENT LLC ($6.9M), CITADEL ADVISORS LLC ($6.8M). Net institutional sentiment: Mixed.
59
Holders
Avg rating(13 Elite)
$52.8M
Total Value
61% (65)
Fund Consensus
34 buying - 22 selling
Who's Trading
ActivistOAOctagon Capital Advisors LP0.0%May 14, 2026
InsiderSDSmethurst DominicSell $51KMar 2, 2026
InsiderHIHodgson IanSell $6KFeb 17, 2026
InsiderCYCohen YuvalSell $108KFeb 13, 2026
InsiderMFMoran Sean F.Sell $37KFeb 13, 2026
ActivistCACormorant Asset Management, LP13.4%Dec 15, 2025
InsiderCLCormorant Asset Management, LPSell $344KDec 11, 2025
InsiderCYCohen YuvalSell $154KOct 27, 2025
13F: Insider & Congress:
Showing 1-20 of 65
1 / 4
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer